Back to search

Article

Gastrin producing syngeneic mesenchymal stem cells protect non-obese diabetic mice from type 1 diabetes

2021-05-15

Abstract excerpt

Progressive destruction of pancreatic islet β-cells by immune cells is a primary feature of type 1 diabetes (T1D) and therapies that can restore the functional β-cell mass are needed to alleviate disease progression. Here, we report the use of mesenchymal stromal/stem cells (MSCs) for the production and delivery of Gastrin, a peptide-hormone which is produced by intestinal cells and fetal islets and can increase β...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
970f8559-03f7-50ae-8f5c-9f0ff0fc3da2
DOI
10.1101/2021.05.13.444059
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gastrin producing syngeneic mesenchymal stem cells protect non-obese diabetic mice from type 1 diabetesDOI 10.1101/2021.05.13.444059
Select a neighboring publication to make it the new centre.